# ORPHENADRINE CITRATE
> **ANDA040327** · Abbreviated New Drug Application (Generic) · Sponsor: SANDOZ · Approved 2000-02-15
## Drug
- **FDA Application Number:** ANDA040327
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ORPHENADRINE CITRATE
- **Generic name:** ORPHENADRINE CITRATE
- **Active ingredients:** ORPHENADRINE CITRATE
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** SANDOZ
- **Manufacturer:** Sandoz Inc
- **First approval:** 2000-02-15
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=040327)
---
*MORVS · CC0 1.0*